Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 7, Pages 1771
Publisher
MDPI AG
Online
2022-04-01
DOI
10.3390/cancers14071771
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
- (2022) Frank J. Lowery et al. SCIENCE
- Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients
- (2021) Elliot Naidus et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mapping the functional landscape of T cell receptor repertoires by single-T cell transcriptomics
- (2021) Ze Zhang et al. NATURE METHODS
- Immune Aging and Immunotherapy in Cancer
- (2021) Melanie Kaiser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autoimmune Responses in Oncology: Causes and Significance
- (2021) Halin Bareke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-throughput and single-cell T cell receptor sequencing technologies
- (2021) Joy A. Pai et al. NATURE METHODS
- Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy
- (2021) Anna Pasetto et al. Frontiers in Immunology
- Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness
- (2021) Chaeun Oh et al. Cancers
- Distinct populations of antigen specific tissue resident CD8 T cells in human cervix mucosa
- (2021) Tao Peng et al. JCI Insight
- Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
- (2021) Antonella Cardinale et al. Frontiers in Immunology
- 76 Spatial mapping of T cell receptors and transcriptomes in renal cell carcinoma following immune checkpoint inhibitor therapy
- (2021) Sophia Liu et al. Journal for ImmunoTherapy of Cancer
- T-Cell Receptor Repertoire Analysis with Computational Tools—An Immunologist’s Perspective
- (2021) Mahima Arunkumar et al. Cells
- Predominance of central memory T cells with high T-cell receptor repertoire diversity is associated with response to PD-1/PD-L1 inhibition in Merkel cell carcinoma
- (2020) Ivelina Spassova et al. CLINICAL CANCER RESEARCH
- T‐cell receptor diversity as a prognostic biomarker in melanoma patients
- (2020) Julie Charles et al. Pigment Cell & Melanoma Research
- TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer
- (2020) Timothy John Looney et al. Frontiers in Immunology
- Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
- (2020) T. Karn et al. ANNALS OF ONCOLOGY
- Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
- (2020) Xiaoxiang Zhou et al. BMC Medicine
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- T‐cell receptor affinity in the age of cancer immunotherapy
- (2020) Michele M. Hoffmann et al. MOLECULAR CARCINOGENESIS
- The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease
- (2020) Katherine Kedzierska et al. VIRAL IMMUNOLOGY
- Demographic and genetic factors influence the abundance of infiltrating immune cells in human tissues
- (2020) Andrew R. Marderstein et al. Nature Communications
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
- (2020) Fangfang Bi et al. Cancer Cell International
- Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
- (2020) Andrew L. Ji et al. CELL
- Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
- (2020) Adrienne M. Luoma et al. CELL
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells
- (2020) Jan A. Rath et al. Science Advances
- Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma
- (2020) Feng Jiang et al. CLINICA CHIMICA ACTA
- T-cell repertoire analysis and metrics of diversity and clonality
- (2020) Johanna Chiffelle et al. CURRENT OPINION IN BIOTECHNOLOGY
- Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
- (2020) Ying Jing et al. Nature Communications
- Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis
- (2020) Rebeca Sanz-Pamplona et al. PLOS MEDICINE
- Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade
- (2020) Weilei Hu et al. iScience
- Association of Tumor Microenvironment T-Cell Repertoire and Mutational Load With Clinical Outcome After Sequential Checkpoint Blockade in Melanoma
- (2019) Erik Yusko et al. Cancer Immunology Research
- Genesis of the αβ T-cell receptor
- (2019) Thomas Dupic et al. PLoS Computational Biology
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
- (2019) Akiko Arakawa et al. Frontiers in Immunology
- The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients
- (2019) Arjun Khunger et al. OncoImmunology
- Tools for fundamental analysis functions of TCR repertoires: a systematic comparison
- (2019) Yanfang Zhang et al. BRIEFINGS IN BIOINFORMATICS
- Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
- (2019) Ibrahim Halil Sahin et al. BRITISH JOURNAL OF CANCER
- Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation
- (2019) Stéphane Buhler et al. LEUKEMIA
- TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
- (2019) Jiefei Han et al. Cancer Immunology Research
- Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy
- (2019) Yi-He Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Cell Biology of T Cell Receptor Expression and Regulation
- (2018) Andrés Alcover et al. Annual Review of Immunology
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does patient age influence anti-cancer immunity?
- (2018) Graham Pawelec Seminars in Immunopathology
- T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma
- (2018) Kai-Rong Lin et al. Cancer Medicine
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- Targeting Macrophages in Cancer: From Bench to Bedside
- (2018) Ashleigh R. Poh et al. Frontiers in Oncology
- TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma
- (2018) Ya-bin Jin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Spatially resolved transcriptomics enables dissection of genetic heterogeneity in stage III cutaneous malignant melanoma
- (2018) Kim Thrane et al. CANCER RESEARCH
- T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer
- (2018) Can Cui et al. CANCER SCIENCE
- Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
- (2018) Sabrina A. Hogan et al. Cancer Immunology Research
- TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
- (2018) Jin-Huan Cui et al. Frontiers in Immunology
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire
- (2017) John F. Beausang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- T cell receptor repertoire usage in cancer as a surrogate marker for immune responses
- (2017) David Schrama et al. Seminars in Immunopathology
- Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
- (2017) Alexandra Snyder et al. PLOS MEDICINE
- A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis
- (2017) Manchao Kuang et al. Scientific Reports
- Variations in MHC Class II Antigen Processing and Presentation in Health and Disease
- (2016) Emil R. Unanue et al. Annual Review of Immunology
- Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire
- (2016) David Y. Oh et al. CANCER RESEARCH
- The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma
- (2016) Colm Keane et al. CLINICAL CANCER RESEARCH
- MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases
- (2016) Sid P. Kerkar et al. JOURNAL OF IMMUNOTHERAPY
- T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma
- (2016) Zengchao Chen et al. JOURNAL OF PATHOLOGY
- Systematic Comparative Evaluation of Methods for Investigating the TCRβ Repertoire
- (2016) Xiao Liu et al. PLoS One
- Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
- (2016) Sumit K. Subudhi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
- (2016) P. L. Stahl et al. SCIENCE
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- The Different T-cell Receptor Repertoires in Breast Cancer Tumors, Draining Lymph Nodes, and Adjacent Tissues
- (2016) Ting Wang et al. Cancer Immunology Research
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy
- (2016) D. B. Page et al. Cancer Immunology Research
- Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
- (2016) Hiroyuki Inoue et al. OncoImmunology
- High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC
- (2016) Yunqing Chen et al. OncoImmunology
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
- (2015) Jamie Rossjohn et al. Annual Review of Immunology
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- αβ T cell receptors as predictors of health and disease
- (2015) Meriem Attaf et al. Cellular & Molecular Immunology
- The MAGE protein family and cancer
- (2015) Jenny L Weon et al. CURRENT OPINION IN CELL BIOLOGY
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors
- (2015) Xueli Bai et al. Scientific Reports
- Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer
- (2015) Qingzhu Jia et al. OncoImmunology
- The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
- (2015) Madhav Sharma et al. Journal for ImmunoTherapy of Cancer
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Towards error-free profiling of immune repertoires
- (2014) Mikhail Shugay et al. NATURE METHODS
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
- (2014) Lidia Robert et al. OncoImmunology
- Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue
- (2013) Anna M. Sherwood et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma
- (2013) Phyu P. Aung et al. HUMAN PATHOLOGY
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- The Past, Present, and Future of Immune Repertoire Biology – The Rise of Next-Generation Repertoire Analysis
- (2013) Adrien Six et al. Frontiers in Immunology
- NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
- (2012) Jin-Ping Lai et al. MODERN PATHOLOGY
- Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
- (2012) Manuarii Manuel et al. OncoImmunology
- MAGE-A family: Attractive targets for cancer immunotherapy
- (2011) Meixiang Sang et al. VACCINE
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Microsatellite instability in colorectal cancer—the stable evidence
- (2010) Eduardo Vilar et al. Nature Reviews Clinical Oncology
- Overlap and Effective Size of the Human CD8+ T Cell Receptor Repertoire
- (2010) H. S. Robins et al. Science Translational Medicine
- Comprehensive assessment of T-cell receptor -chain diversity in T cells
- (2009) H. S. Robins et al. BLOOD
- High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer
- (2009) Alain Bergeron et al. INTERNATIONAL JOURNAL OF CANCER
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
- (2008) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now